Skip to main content
Erschienen in: Supportive Care in Cancer 3/2021

22.07.2020 | Original Article

The dyadic relationship of benefit finding and its impact on quality of life in colorectal cancer survivor and spousal caregiver couples

verfasst von: Yi Lin, Xingjuan Luo, Jieyu Li, Yinghua Xu, Qiuping Li

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To explore the benefit finding (BF) relationship between colorectal cancer (CRC) survivors and their spousal caregivers, and to discover the dyadic impact of BF on quality of life (QOL) in CRC survivor and spousal caregiver couples.

Methods

Conducted from May 2018 to December 2018, the study included 286 couples consisting of CRC survivors and their spousal caregivers. The study survey evaluated participants’ BF, anxiety, depression, and QOL. Data analysis methods included Pearson’s correlation, paired t test, and the actor-partner interdependence mediation model (APIMeM).

Results

CRC survivors and spousal caregivers reported comparable moderate to high BF experience (ranging from 68.9 to 80.8%). Moderate to high correlations were found between CRC survivors and their spousal caregivers in all of the paired BFs (including the overall BF scale and three factors) (all Ps < 0.001, r = 0.461–0.612). We found significant positive correlations of the same measures between dyads of CRC survivors and spousal caregivers (r = 0.331–0.612), including BFS-C (overall BF scale and three subscales), HADS-C (anxiety and depression), PCS, and MCS. To a certain degree, BF exerts an impact on couples’ QOL through the mediating effect of psychological distress (anxiety and depression).

Conclusions

The present study further confirms the dyadic interdependence between BF, anxiety, depression, and QOL in couples coping with CRC. In addition, the APIMeM findings may support the proposed mechanism, in that buffering against negative emotions (psychological distress) is an approach in which BF plays an important role, e.g., improves QOL, in the context of a stressful process.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
4.
Zurück zum Zitat Hagedoorn M, Sanderman R, Bolks HN, Tuinstra J, Coyne JC (2008) Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull 134(1):1–30CrossRefPubMed Hagedoorn M, Sanderman R, Bolks HN, Tuinstra J, Coyne JC (2008) Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull 134(1):1–30CrossRefPubMed
5.
Zurück zum Zitat Northouse LL, Mood D, Templin T, Mellon S, George T (2000) Couples’ patterns of adjustment to colon cancer. Soc Sci Med 50(2):271–284CrossRefPubMed Northouse LL, Mood D, Templin T, Mellon S, George T (2000) Couples’ patterns of adjustment to colon cancer. Soc Sci Med 50(2):271–284CrossRefPubMed
11.
Zurück zum Zitat Folkman S (1997) Positive psychological states and coping with severe stress. Soc Sci Med 45(8):1207–1221CrossRefPubMed Folkman S (1997) Positive psychological states and coping with severe stress. Soc Sci Med 45(8):1207–1221CrossRefPubMed
20.
Zurück zum Zitat Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM, Yount SE, McGregor BA, Arena PL, Harris SD, Price AA, Carver CS (2001) Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol 20(1):20–32CrossRefPubMed Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM, Yount SE, McGregor BA, Arena PL, Harris SD, Price AA, Carver CS (2001) Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol 20(1):20–32CrossRefPubMed
24.
Zurück zum Zitat Wang YLLYY, Cai L, Chen G, Tang L, Zhu X (2013) Reliability and validity of the benefit finding scale in women with breast cancer. Chin J Clin Psychol 21:410–412 Wang YLLYY, Cai L, Chen G, Tang L, Zhu X (2013) Reliability and validity of the benefit finding scale in women with breast cancer. Chin J Clin Psychol 21:410–412
26.
Zurück zum Zitat Zhu L, Ranchor AV, Helgeson VS, van der Lee M, Garssen B, Stewart RE, Sanderman R, Schroevers MJ (2018) Benefit finding trajectories in cancer patients receiving psychological care: predictors and relations to depressive and anxiety symptoms. Br J Health Psychol 23(2):238–252. https://doi.org/10.1111/bjhp.12283CrossRefPubMed Zhu L, Ranchor AV, Helgeson VS, van der Lee M, Garssen B, Stewart RE, Sanderman R, Schroevers MJ (2018) Benefit finding trajectories in cancer patients receiving psychological care: predictors and relations to depressive and anxiety symptoms. Br J Health Psychol 23(2):238–252. https://​doi.​org/​10.​1111/​bjhp.​12283CrossRefPubMed
33.
Zurück zum Zitat von Heymann-Horan A, Bidstrup PE (2019) Dyadic coping in specialized palliative care intervention for patients with advanced cancer and their caregivers: effects and mediation in a randomized controlled trial. Psycho-oncology 28(2):264–270. https://doi.org/10.1002/pon.4932CrossRef von Heymann-Horan A, Bidstrup PE (2019) Dyadic coping in specialized palliative care intervention for patients with advanced cancer and their caregivers: effects and mediation in a randomized controlled trial. Psycho-oncology 28(2):264–270. https://​doi.​org/​10.​1002/​pon.​4932CrossRef
35.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed
37.
Zurück zum Zitat Ware JJ, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220–233CrossRefPubMed Ware JJ, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220–233CrossRefPubMed
38.
Zurück zum Zitat Ware JE, Kosinski M, Turner-Bowker DM, Gandek B (2002) How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). QualityMetric Incorporated, Ware JE, Kosinski M, Turner-Bowker DM, Gandek B (2002) How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). QualityMetric Incorporated,
39.
Zurück zum Zitat Portney LG, Watkins MP (2009) Foundations of clinical research: applications to practice, 3rd edn. Pearson/Prentice Hall, London Portney LG, Watkins MP (2009) Foundations of clinical research: applications to practice, 3rd edn. Pearson/Prentice Hall, London
41.
Zurück zum Zitat Cook WL, Kenny DA (2005) The actor–partner interdependence model: a model of bidirectional effects in developmental studies. Int J Behav Dev 29(2):101–109CrossRef Cook WL, Kenny DA (2005) The actor–partner interdependence model: a model of bidirectional effects in developmental studies. Int J Behav Dev 29(2):101–109CrossRef
42.
Zurück zum Zitat Kenny DA, Kashy DA, Cook WL (2006) Dyadic data analysis. Guilford Press, New York Kenny DA, Kashy DA, Cook WL (2006) Dyadic data analysis. Guilford Press, New York
Metadaten
Titel
The dyadic relationship of benefit finding and its impact on quality of life in colorectal cancer survivor and spousal caregiver couples
verfasst von
Yi Lin
Xingjuan Luo
Jieyu Li
Yinghua Xu
Qiuping Li
Publikationsdatum
22.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05602-x

Weitere Artikel der Ausgabe 3/2021

Supportive Care in Cancer 3/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.